← All stocks

Schrodinger, Inc.

SDGR Scheduled selling only
CIK 0001490978 #2259 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$1.40M
$346.99K on a plan · $1.06M straight out of an exercise
Sold at will
$0.00
0 of 19 sales
Net
−$1.40M
$0.00 against sales at will

By person

19 insiders · 20 transactions
8.6×

Ramy Farid holds 8.6 times base salary in stock. $6.32M of shares against $730.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Ramy Farid last reported holding, valued at $15.60, the price Common Stock was last bought or sold at on the open market here, on 16 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Farid Ramy
President & CEO
$1.17M (4) scheduled
−$1.17M
405,351
0.543%
$6.32M
+119.8%
Jain Rachit
EVP & CFO
$45.44K (3) scheduled
−$45.44K
50,877
0.068%
$793.53K
+83.5%
Akinsanya Karen
See Remarks
$44.08K (2) scheduled
−$44.08K
69,956
0.094%
$1.09M
Abel Robert Lorne
See Remarks
$33.27K (2) scheduled
−$33.27K
55,897
0.075%
$871.83K
+498.5%
Dugan Margaret
Chief Medical Officer
$29.39K (1) scheduled
−$29.39K
24,574
0.033%
$383.28K
+63.8%
Lorton Kenneth Patrick
EVP, CTO & COO, Software
$28.47K (2) scheduled
−$28.47K
89,241
0.119%
$1.39M
+112.2%
Herman Jenny
CAO
$28.13K (3) scheduled
−$28.13K
34,804
0.047%
$542.84K
+82.5%
Tran Yvonne
EVP, CLO & CPO
$24.81K (2) scheduled
−$24.81K
52,683
0.071%
$821.70K
+340.4%
Friesner Richard
Director
1,369,738
1.8%
$21.36M
+14.6%
Aklian Mannix Vartan
See Remarks
31,193
0.042%
$486.52K
Porges Geoffrey Craig
EVP & CFO
27,544
0.037%
$429.60K
+384.5%
Lynton Michael
Director
25,388
0.034%
$395.98K
+125.7%
Thornberry Nancy
Director
25,388
0.034%
$395.98K
+125.7%
Chodakewitz Jeffrey
Director
25,388
0.034%
$395.98K
+125.7%
OBEROI ARUN
Director
25,388
0.034%
$395.98K
+125.7%
Sender Gary
Director
25,388
0.034%
$395.98K
+125.7%
GINSBERG GARY L
Director
25,388
0.034%
$395.98K
+125.7%
Kapeller-Libermann Rosana
Director
25,388
0.034%
$395.98K
+125.7%
van Kralingen Bridget A
Director
19,640
0.026%
$306.33K
Insider
Date
Role
Action
Shares
Price
Amount
Farid Ramy
17 Apr 2026
President & CEO
Sold after exercise
43,000
$12.21
$524.94K
Farid Ramy
16 Apr 2026
President & CEO
Sold after exercise
43,000
$12.33
$530.23K

What was left out

Form 4 filings counted 34
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,079,477
History held since 10 Feb 2020